News
StockStory.org on MSN3d
10x Genomics’s (NASDAQ:TXG) Q1: Strong Sales But Quarterly Revenue Guidance Significantly Misses ExpectationsBiotech company 10x Genomics (NASDAQ:TXG) reported Q1 CY2025 results , with sales up 9.8% year on year to $154.9 million. On ...
Despite a challenging macro environment, 10x Genomics Inc (TXG) showcases resilience with strong consumables growth and ...
3d
Zacks Investment Research on MSNCompared to Estimates, 10x Genomics (TXG) Q1 Earnings: A Look at Key MetricsFor the quarter ended March 2025, 10x Genomics (TXG) reported revenue of $154.88 million, up 9.8% over the same period last year. EPS came in at -$0.36, compared to -$0.50 in the year-ago quarter. The ...
StockStory.org on MSN5d
10x Genomics (TXG) Reports Q1: Everything You Need To Know Ahead Of EarningsBiotech company 10x Genomics (NASDAQ:TXG) will be announcing earnings results tomorrow after the bell. Here’s what investors ...
10X GENOMICS ($TXG) posted quarterly earnings results on Thursday, May 8th. The company reported earnings of -$0.36 per share, beating estimates of -$0.48 by $0.12 ...
Detailed price information for 10X Genomics Inc (TXG-Q) from The Globe and Mail including charting and trades.
As you might know, 10x Genomics, Inc. ( NASDAQ:TXG ) just kicked off its latest quarterly results with some very ...
Ladies and gentlemen, thank you so much for standing by and welcome to 10x Genomics First Quarter 2025 Earnings Conference Call. Please note that this call is being recorded. After speakers ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results